Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
24.96
+0.69 (2.84%)
At close: Aug 13, 2025, 4:00 PM
25.10
+0.14 (0.56%)
After-hours: Aug 13, 2025, 6:37 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.46 billion as of August 13, 2025. Its market cap has decreased by -36.05% in one year.
Market Cap
1.46B
Enterprise Value
484.66M
1-Year Change
-36.05%
Ranking
Category
Stock Price
$24.96
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.46B, an increase of 137.64%. That is a compound annual growth rate of 23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 1.46B | -52.75% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |